Reply to v.R. Bhatt et Al and m.C. Chamberlain.
James W
JW
Welsh
Susan L
SL
McGovern
Jeffrey S
JS
Wefel
Ritsuko
R
Komaki
Paul D
PD
Brown
Hendrick E
HE
Soh
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000556:secondary* / Q000628:therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000556:secondary* / Q000628:therapy*; D016371:Cranial Irradiation; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D009154:Mutation; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors